WW International, Inc. (WW) Bundle
Understanding WW International, Inc. (WW) Revenue Streams
Understanding WW International, Inc.’s Revenue Streams
Revenues for the third quarter of fiscal 2024 were $192.9 million, a decrease of $22.0 million, or 10.2%, versus the third quarter of fiscal 2023. Excluding the impact of foreign currency, revenues would have decreased by 10.6%.
For the first nine months of fiscal 2024, revenues were $601.5 million, a decrease of $82.1 million, or 12.0%, compared to the first nine months of fiscal 2023.
Breakdown of Primary Revenue Sources
The primary revenue sources include:
- Subscription Revenues:
- Q3 2024: $191.2 million
- Q3 2023: $203.5 million
- First 9 months 2024: $595.3 million
- First 9 months 2023: $626.7 million
- Other Revenues:
- Q3 2024: $1.6 million
- Q3 2023: $11.4 million
- First 9 months 2024: $6.2 million
- First 9 months 2023: $56.9 million
Year-over-Year Revenue Growth Rate
The year-over-year revenue growth rates are as follows:
- Q3 2024 vs. Q3 2023:
- Subscription Revenue: -6.0%
- Other Revenue: -85.6%
- Total Revenue: -10.2%
- First 9 months 2024 vs. First 9 months 2023:
- Subscription Revenue: -5.0%
- Other Revenue: -89.0%
- Total Revenue: -12.0%
Contribution of Different Business Segments to Overall Revenue
The contribution of different business segments to overall revenue for the first nine months of fiscal 2024 was as follows:
| Segment | Revenue (in millions) | Percentage of Total Revenue |
|---|---|---|
| Subscription Revenues | $595.3 | 99.0% |
| Other Revenues | $6.2 | 1.0% |
| Total Revenues | $601.5 | 100% |
Analysis of Significant Changes in Revenue Streams
Significant changes in revenue streams include:
- Decline in Subscription Revenues primarily attributed to recruitment declines and a higher mix of Digital subscribers within lower-priced commitment periods.
- Decrease in Other Revenues due to the discontinuation of the consumer products business at the end of fiscal 2023.
Clinical Subscription Revenues for the first nine months of fiscal 2024 amounted to $57.5 million compared to $17.6 million in the same period of fiscal 2023.
The overall gross margin for the first nine months of fiscal 2024 increased to 67.3% from 59.2% in the prior year, driven by cost reductions and the discontinuation of lower-margin businesses.
A Deep Dive into WW International, Inc. (WW) Profitability
A Deep Dive into WW International, Inc.'s Profitability
Gross Profit Margin: For the third quarter of fiscal 2024, the gross profit was $129.5 million, resulting in a gross margin of 67.1%. In comparison, the gross profit for the third quarter of fiscal 2023 was $141.8 million with a gross margin of 66.0%.
Operating Profit Margin: The operating loss for Q3 2024 was ($39.0 million), leading to an operating margin of (20.2%). This contrasts sharply with an operating income of $30.6 million and a margin of 14.2% in Q3 2023.
Net Profit Margin: The net loss for the third quarter of fiscal 2024 was ($46.2 million), resulting in a net margin of (24.0%). In the same quarter of fiscal 2023, net income was $43.7 million with a net margin of 20.3%.
| Metric | Q3 2024 | Q3 2023 | % Change |
|---|---|---|---|
| Gross Profit | $129.5 million | $141.8 million | (8.6%) |
| Gross Margin | 67.1% | 66.0% | 1.1% |
| Operating Income | ($39.0 million) | $30.6 million | (227.6%) |
| Operating Margin | (20.2%) | 14.2% | (34.4%) |
| Net Income | ($46.2 million) | $43.7 million | (206.6%) |
| Net Margin | (24.0%) | 20.3% | (44.3%) |
Trends in Profitability: Over the first nine months of fiscal 2024, gross profit totaled $404.6 million with a gross margin of 67.3%, compared to $404.4 million and 59.2% in the same period of fiscal 2023. Operating loss for the first nine months of 2024 was ($272.4 million), with an operating margin of (45.3%), compared to an operating income of $28.3 million and a margin of 4.1% in 2023.
Comparison with Industry Averages: The average gross margin for the industry stands at approximately 60% to 65%, indicating that the company is performing relatively well in terms of gross profitability. However, the significant decline in operating margin and net income margin suggests operational challenges.
Operational Efficiency: Cost of revenues decreased by 29.5% in the first nine months of fiscal 2024, totaling $196.9 million, compared to $279.1 million in the prior year. This indicates improved cost management despite the overall losses.
Marketing expenses for the first nine months of fiscal 2024 were $188.3 million, a marginal increase of 0.4% from $187.5 million in the previous year, suggesting a strategic focus on retaining customer engagement amidst declining revenues.
Overall, the company has made strides in gross margin improvement while facing substantial challenges in operating and net profitability.
Debt vs. Equity: How WW International, Inc. (WW) Finances Its Growth
Debt vs. Equity: How WW International, Inc. Finances Its Growth
Overview of the Company's Debt Levels
As of September 28, 2024, the company reported a total debt of $1,445.0 million, which comprises:
- Term Loan Facility due April 13, 2028: $945.0 million
- Senior Secured Notes due April 15, 2029: $500.0 million
The company had no current portion of debt due at this date. After accounting for unamortized deferred financing costs of $7.4 million and unamortized debt discount of $8.0 million, the total long-term debt was $1,429.6 million.
Debt-to-Equity Ratio and Comparison to Industry Standards
The debt-to-equity ratio for the company as of September 28, 2024, was reported at 10.4x. This ratio is significantly higher than the industry average, indicating a heavier reliance on debt financing compared to equity. The industry average for similar companies typically ranges between 0.5x to 2.0x.
Recent Debt Issuances, Credit Ratings, or Refinancing Activity
In April 2021, the company refinanced its existing credit facilities, incurring approximately $1,000.0 million in new borrowings under its Credit Facilities and issuing $500.0 million in aggregate principal amount of Senior Secured Notes. As of September 28, 2024, the company had no outstanding borrowings under its $175.0 million Revolving Credit Facility.
Credit ratings reflect the company's financial health, with the most recent evaluations indicating a stable outlook, although specific ratings were not disclosed in the latest reports.
How the Company Balances Between Debt Financing and Equity Funding
The company has focused on reducing leverage as a priority in its capital structure. The net debt to Adjusted EBITDAS ratio stood at 10.4x, illustrating a significant burden of debt relative to earnings. The weighted average interest rate on outstanding debt was approximately 7.77% as of September 28, 2024, compared to 7.64% at December 30, 2023.
| Debt Type | Amount (in millions) | Due Date | Interest Rate |
|---|---|---|---|
| Term Loan Facility | $945.0 | April 13, 2028 | 9.43% |
| Senior Secured Notes | $500.0 | April 15, 2029 | 4.64% |
| Total Debt | $1,445.0 |
To meet its long-term obligations, the company plans to utilize cash flows from operations and may consider refinancing options as necessary. The company has demonstrated a willingness to manage its capital structure actively, as evidenced by the restructuring activities implemented in response to changing market conditions.
Assessing WW International, Inc. (WW) Liquidity
Assessing Liquidity and Solvency
Current and Quick Ratios
The current ratio as of September 28, 2024, is 0.53, calculated as total current assets of $101.2 million divided by total current liabilities of $189.5 million. The quick ratio, which excludes inventory from current assets, is 0.26.
Analysis of Working Capital Trends
Working capital as of September 28, 2024, shows a deficit of $88.2 million, compared to a deficit of $26.0 million at the end of the previous fiscal year on December 30, 2023. The working capital deficit, excluding cash and cash equivalents, increased to $145.4 million from $135.4 million during the same period.
| Measure | September 28, 2024 | December 30, 2023 | Change |
|---|---|---|---|
| Total Current Assets | $101.2 million | $179.5 million | ($78.3 million) |
| Total Current Liabilities | $189.5 million | $205.5 million | ($16.0 million) |
| Working Capital Deficit | ($88.2 million) | ($26.0 million) | ($62.2 million) |
| Working Capital Deficit (excl. Cash) | ($145.4 million) | ($135.4 million) | ($10.0 million) |
Cash Flow Statements Overview
For the nine months ended September 28, 2024, cash flows reflect significant outflows across all activities:
- Net cash used for operating activities: ($21.4 million)
- Net cash used for investing activities: ($13.2 million)
- Net cash used for financing activities: ($17.1 million)
Comparatively, for the nine months ended September 30, 2023, cash flows were:
- Net cash used for operating activities: ($1.2 million)
- Net cash used for investing activities: ($66.7 million)
- Net cash used for financing activities: ($1.9 million)
Potential Liquidity Concerns or Strengths
The substantial increase in the net loss to ($370.8 million) for the first nine months of fiscal 2024, compared to ($24.1 million) for the same period in fiscal 2023, raises liquidity concerns. Additionally, the company has long-term debt obligations totaling $1.4296 billion as of September 28, 2024, with significant interest expenses increasing by 14.7% year-over-year.
| Debt Measure | Amount |
|---|---|
| Term Loan Facility | $945.0 million |
| Senior Secured Notes | $500.0 million |
| Total Long-Term Debt | $1,429.6 million |
| Interest Expense (9 months 2024) | $81.9 million |
Is WW International, Inc. (WW) Overvalued or Undervalued?
Valuation Analysis
To assess whether the company is overvalued or undervalued, we will examine key valuation ratios, stock price trends, dividend yield, and analyst consensus.
Price-to-Earnings (P/E) Ratio
The P/E ratio as of September 28, 2024, is calculated using the diluted earnings per share (EPS). The company reported a diluted net loss per share of $0.58 for Q3 2024, compared to earnings of $0.54 for Q3 2023.
Price-to-Book (P/B) Ratio
The P/B ratio is calculated using the book value per share. As of September 28, 2024, total assets were $562.4 million and total liabilities were $1.7 billion, resulting in a total deficit of $1.1 billion. The book value per share is therefore negative, indicating a P/B ratio that is not applicable.
Enterprise Value-to-EBITDA (EV/EBITDA)
The company's enterprise value is calculated as total debt minus cash and cash equivalents, adjusted for market capitalization. As of September 28, 2024, total debt is $1.4 billion and cash equivalents are $57.2 million, leading to an enterprise value of approximately $1.4 billion. The EBITDA for the trailing twelve months is not explicitly provided, but operating loss was reported at $272.4 million for the first nine months of fiscal 2024.
| Metric | Value |
|---|---|
| P/E Ratio | N/A (Negative EPS) |
| P/B Ratio | N/A (Negative Book Value) |
| EV/EBITDA | N/A (Negative EBITDA) |
Stock Price Trends
The stock price has fluctuated significantly over the past 12 months. As of September 28, 2024, the stock price was $4.34 per share. Over the past year, the stock has experienced a decline from approximately $9.00 in early October 2023.
Dividend Yield and Payout Ratios
The company does not currently pay a dividend, which results in a dividend yield of 0%. Given the negative earnings and overall financial distress, no payout ratios can be calculated.
Analyst Consensus
As of the latest reports, analyst consensus suggests a rating of Sell based on the company's financial performance and outlook. Analysts have expressed concerns regarding the company's ability to maintain liquidity and generate positive cash flows in the near future.
| Analyst Rating | Consensus |
|---|---|
| Current Rating | Sell |
The current financial metrics indicate a challenging valuation landscape for the company, characterized by negative earnings and significant liabilities.
Key Risks Facing WW International, Inc. (WW)
Key Risks Facing WW International, Inc.
WW International, Inc. faces several risk factors that could significantly impact its financial health and operational stability.
1. Industry Competition
The company operates in a highly competitive market characterized by the increasing popularity of weight management medications and wellness programs. The rise of digital health platforms and alternative weight loss solutions could further intensify competition.
2. Regulatory Changes
Changes in regulations, particularly related to health and wellness, could impact operational costs and compliance requirements. The adoption of the OECD's global tax reform initiative, imposing a global minimum tax of 15% on large multinational corporations, could also affect financial outcomes without immediate impact on the effective tax rate .
3. Market Conditions
Fluctuations in market demand for weight management services, changes in consumer preferences, and economic downturns could adversely affect revenue growth. The company reported a net revenue decline of 12%, from $683.6 million in the first nine months of fiscal 2023 to $601.5 million in the same period of fiscal 2024 .
4. Operational Risks
Operational challenges include maintaining effective marketing strategies and managing costs. The company's gross profit margin decreased slightly, reflecting pressures from increased marketing expenses .
5. Financial Risks
The company is currently experiencing significant financial losses, with a net loss of $370.8 million for the nine months ended September 28, 2024, compared to a loss of $24.1 million for the same period in the previous year . The diluted net loss per share was $4.67 for the nine months ended September 28, 2024 .
6. Debt Obligations
As of September 28, 2024, the company had total debt of $1.445 billion. The weighted average interest rate on outstanding debt was approximately 7.77% . High debt levels could limit financial flexibility and increase vulnerability to interest rate fluctuations.
7. Franchise Rights Impairments
The company recorded a $315 million impairment charge related to franchise rights acquired in fiscal 2024 . Such impairments indicate underlying challenges in maintaining the value of acquired business assets.
8. Cash Flow and Liquidity Risks
Liquidity is a concern as cash and cash equivalents decreased from $109.4 million at December 30, 2023, to $57.2 million at September 28, 2024 . If the company fails to generate sufficient cash flow, it may need to refinance debt or seek additional financing, which could adversely affect financial condition and operational capabilities.
9. Legal Risks
The company is subject to ongoing legal proceedings which could result in unforeseen liabilities. While management does not expect material adverse effects from these actions, the unpredictability of legal outcomes remains a risk factor .
10. Foreign Currency Risks
Foreign currency fluctuations can impact financial performance. For the third quarter of fiscal 2024, the company reported a foreign currency translation income of $3.8 million . However, adverse currency movements could still negatively affect revenues and expenses in international markets.
| Risk Factor | Description | Potential Impact |
|---|---|---|
| Industry Competition | Increasing competition from digital health platforms and weight management medications. | Revenue decline and market share loss. |
| Regulatory Changes | Changes in health regulations and taxes impacting operational costs. | Increased compliance costs and potential tax liabilities. |
| Market Conditions | Fluctuations in demand for weight management services. | Revenue volatility and customer retention challenges. |
| Operational Risks | Challenges in marketing effectiveness and cost management. | Reduced profitability margins. |
| Financial Risks | High operational losses and negative earnings per share. | Increased scrutiny from investors and potential liquidity issues. |
| Debt Obligations | Total debt of $1.445 billion with high interest costs. | Financial strain and reduced operational flexibility. |
| Franchise Rights Impairments | Significant impairment charges affecting asset values. | Negative impact on financial statements and investor confidence. |
| Cash Flow and Liquidity Risks | Declining cash reserves affecting operational funding. | Need for refinancing or asset sales, impacting growth. |
| Legal Risks | Ongoing legal proceedings with uncertain outcomes. | Potential for unforeseen liabilities. |
| Foreign Currency Risks | Impact of currency fluctuations on international operations. | Revenue and expense volatility. |
Future Growth Prospects for WW International, Inc. (WW)
Growth Opportunities
Future Growth Prospects for WW International, Inc.
In 2024, WW International, Inc. is positioned to leverage several key growth drivers that could enhance its market presence and financial performance.
Key Growth Drivers
- Product Innovations: The company has focused on enhancing its digital offerings, including a mobile app that integrates personalized weight management solutions. The acquisition of Sequence, a technology-powered care platform, for an aggregate amount of $132 million is expected to boost its service offerings .
- Market Expansions: WW is targeting international markets for expansion, particularly in Europe and Asia, where demand for health and wellness services is increasing. The company's strategy includes local partnerships to enhance regional market penetration.
- Acquisitions: The recent acquisition of Sequence is a strategic move to diversify its service portfolio and attract a broader customer base .
Future Revenue Growth Projections and Earnings Estimates
For the fiscal year 2024, the total revenues are projected to be $601.5 million, reflecting a decline of 12% year-over-year. The subscription revenues are estimated at $595.3 million, with an anticipated slight recovery in subsequent years as new products and services gain traction.
Strategic Initiatives and Partnerships
WW International has entered into several strategic partnerships aimed at enhancing customer engagement and retention. These initiatives include collaborations with fitness influencers and health professionals to promote its digital services. The company has also increased its marketing spend by 0.4% in 2024, primarily focusing on online advertising.
| Initiative | Details | Expected Impact |
|---|---|---|
| Acquisition of Sequence | Paid $132 million for a subscription-based health platform | Enhance digital offerings and customer base diversification |
| Market Expansion | Focus on Europe and Asia | Increase market share and revenue growth potential |
| Strategic Partnerships | Collaborations with health professionals | Improve customer engagement and retention |
Competitive Advantages
WW International possesses several competitive advantages that position it favorably for growth:
- Brand Recognition: Established brand presence in the weight management sector enhances customer trust and loyalty.
- Digital Transformation: A robust digital platform with personalized solutions attracts tech-savvy consumers.
- Comprehensive Service Offerings: The integration of nutritional advice, fitness coaching, and medical support through acquisitions like Sequence enhances value proposition.
Financial Overview
As of September 28, 2024, the company's total long-term debt is $1.445 billion, with a net debt of $1.372 billion. Despite facing a net loss of $370.8 million in the first nine months of fiscal 2024, strategic initiatives are expected to improve financial health in the coming years.
| Financial Metric | 2024 | 2023 |
|---|---|---|
| Total Revenues | $601.5 million | $683.6 million |
| Net Loss | $370.8 million | $24.1 million |
| Long-Term Debt | $1.445 billion | $1.426 billion |
| Cash and Cash Equivalents | $57.2 million | $109.4 million |
WW International, Inc. (WW) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Updated on 16 Nov 2024
Resources:
- WW International, Inc. (WW) Financial Statements – Access the full quarterly financial statements for Q3 2024 to get an in-depth view of WW International, Inc. (WW)' financial performance, including balance sheets, income statements, and cash flow statements.
- SEC Filings – View WW International, Inc. (WW)' latest filings with the U.S. Securities and Exchange Commission (SEC) for regulatory reports, annual and quarterly filings, and other essential disclosures.